Sirio Pharma Co., Ltd. (300791.SZ)
CNY 28.09
(-0.46%)
CNY 28.09
(-0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.58 Billion CNY | 42.87% |
| 2022 | 2.5 Billion CNY | 5.84% |
| 2021 | 2.36 Billion CNY | 14.62% |
| 2020 | 2.06 Billion CNY | 30.85% |
| 2019 | 1.57 Billion CNY | -0.99% |
| 2018 | 1.59 Billion CNY | 19.91% |
| 2017 | 1.33 Billion CNY | 69.23% |
| 2016 | 786.19 Million CNY | -4.64% |
| 2015 | 824.43 Million CNY | 5.89% |
| 2014 | 778.6 Million CNY | 11.44% |
| 2013 | 698.67 Million CNY | 26.17% |
| 2012 | 553.77 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 951.5 Million CNY | -11.82% |
| 2024 Q3 | 1.05 Billion CNY | 2.46% |
| 2024 Q2 | 1.03 Billion CNY | 8.52% |
| 2023 Q1 | 702.15 Million CNY | -2.34% |
| 2023 FY | 3.58 Billion CNY | 42.87% |
| 2023 Q4 | 1.07 Billion CNY | 12.63% |
| 2023 Q3 | 958.07 Million CNY | 13.69% |
| 2023 Q2 | 842.68 Million CNY | 20.01% |
| 2022 FY | 2.5 Billion CNY | 5.84% |
| 2022 Q4 | 718.99 Million CNY | 6.22% |
| 2022 Q2 | 690.14 Million CNY | 63.83% |
| 2022 Q1 | 421.24 Million CNY | -32.16% |
| 2022 Q3 | 676.86 Million CNY | -1.92% |
| 2021 FY | 2.36 Billion CNY | 14.62% |
| 2021 Q1 | 507.56 Million CNY | -17.27% |
| 2021 Q2 | 657.47 Million CNY | 29.54% |
| 2021 Q3 | 582.93 Million CNY | -11.34% |
| 2021 Q4 | 620.98 Million CNY | 6.53% |
| 2020 Q2 | 557.31 Million CNY | 55.48% |
| 2020 Q4 | 613.47 Million CNY | 14.12% |
| 2020 Q1 | 358.45 Million CNY | -13.03% |
| 2020 Q3 | 537.57 Million CNY | -3.54% |
| 2020 FY | 2.06 Billion CNY | 30.85% |
| 2019 Q3 | 382.38 Million CNY | -4.69% |
| 2019 FY | 1.57 Billion CNY | -0.99% |
| 2019 Q1 | 383.8 Million CNY | -16.06% |
| 2019 Q2 | 401.21 Million CNY | 4.54% |
| 2019 Q4 | 412.14 Million CNY | 7.78% |
| 2018 Q4 | 457.23 Million CNY | 14.39% |
| 2018 Q3 | 399.7 Million CNY | 0.0% |
| 2018 FY | 1.59 Billion CNY | 19.91% |
| 2017 FY | 1.33 Billion CNY | 69.23% |
| 2016 FY | 786.19 Million CNY | -4.64% |
| 2015 Q4 | 237.9 Million CNY | 0.0% |
| 2015 FY | 824.43 Million CNY | 5.89% |
| 2014 FY | 778.6 Million CNY | 11.44% |
| 2013 FY | 698.67 Million CNY | 26.17% |
| 2012 FY | 553.77 Million CNY | 0.0% |